Cantharidin Application in Molluscum Patients-1 (CAMP-1)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
Sponsor: Database Integrations, Inc.
This PHASE3 trial investigates Molluscum Contagiosum and is currently completed. Database Integrations, Inc. leads this study, which shows 18 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
18 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Feb 2022 — Jul 2024 [monthly]
Completed PHASE3
-
Jan 2022 — Feb 2022 [monthly]
Completed PHASE3
▶ Show 13 earlier versions
-
Jan 2021 — Jan 2022 [monthly]
Completed PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Feb 2020 — Jul 2020 [monthly]
Completed PHASE3
-
Jul 2019 — Feb 2020 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Nov 2018 — Jul 2019 [monthly]
Active Not Recruiting PHASE3
-
Oct 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Recruiting PHASE3
-
Aug 2018 — Sep 2018 [monthly]
Recruiting PHASE3
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE3
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE3
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Feb 2018 — May 2018 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2018 — Feb 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Database Integrations, Inc.
- Instat Consulting, Inc.
- Paidion Research, Inc.
- Verrica Pharmaceuticals Inc.
For direct contact, visit the study record on ClinicalTrials.gov .